You cannot register anymore for this webinar

ECM Remodeling and Precision Trials in Pulmonary Diseases

From Heterogeneity to Biology

Join our webinar to explore whether current approaches truly capture the underlying biology pulmonary diseases such as COPD and lung cancer. This session focuses on extracellular matrix (ECM) remodeling as a central disease mechanism, its role in disease heterogeneity, and how ECM-derived biomarkers may support precision trials and improved prognostic assessment.

​​​​​​​Learn more
Missed the webinar? Watch the replay!

Format
60-70 minutes presentation followed by 20-30 minutes of audience Q&A.

Agenda
Welcome and introduction

COPD heterogeneity and extracellular matrix remodeling as a core disease mechanism

ECM biomarkers as tools for disease activity and prognosis – Assessing critical pathways of disease

From COPD to Lung Cancer – The ECM as a pro-tumor environment

Speakers
Dr. Janette Burgess 
Dr. Morten Karsdal
Dr. Diana Julie Leeming
​​​​​​​
Expected duration
90 minutes



Share this webinar